{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [],
  "article_type": null,
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "name": "Joshua Robert Goulding",
      "orcid": "0000-0001-7127-092X"
    },
    {
      "name": "Stijn Tim Couwenbergh"
    },
    {
      "name": "Sarah-Lee Bekaert"
    },
    {
      "name": "Ellen Sanders"
    },
    {
      "name": "Fanny De Vloed"
    },
    {
      "name": "Vicky Amo-Addae"
    },
    {
      "name": "Aline Eggermont"
    },
    {
      "name": "Jolien De Wyn"
    },
    {
      "name": "Kaat De Wever"
    },
    {
      "name": "Lasse Vleminckx"
    },
    {
      "name": "Selma Eising"
    },
    {
      "name": "Jan J. Molenaar"
    },
    {
      "name": "Marlinde L. van den Boogaard"
    },
    {
      "name": "Lisa Depestel"
    },
    {
      "name": "Kaat Durinck"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6fq5mks71zgvs.bib",
  "cited_by": 0,
  "doi": "10.1016/j.celrep.2026.117997",
  "fulltext_url": null,
  "id": "6fq5mks71zgvs",
  "issns": [
    "2211-1247"
  ],
  "landing_url": "https://linkinghub.elsevier.com/retrieve/pii/S2211124726010752",
  "language": null,
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "http://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2728|Neuroblastoma Research and Treatments"
    ]
  ],
  "openalex": "W7221526301",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-01",
  "publisher": "Elsevier BV",
  "ris": "https://research.draconitic.com/paper/6fq5mks71zgvs.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:34Z",
      "native_id": "10.1016/j.celrep.2026.117997",
      "source": "crossref",
      "url": "https://linkinghub.elsevier.com/retrieve/pii/S2211124726010752"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2728|Neuroblastoma Research and Treatments",
      "subfield": "neurology"
    }
  ],
  "title": "Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma",
  "title_text": "Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:19:34Z",
  "url": "https://research.draconitic.com/paper/6fq5mks71zgvs",
  "venue": "Cell Reports",
  "versions": []
}